Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04462237 · ClinicalTrials.gov registry record · NA
Recombinant Human Platelet-derived Growth Factor in Combination With Collagen Matrix
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04462237 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 30 participants.
The verdict
NCT04462237, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The present randomized clinical trial is aimed at evaluating the efficacy of recombinant human platelet-derived growth factor in combination with collagen matrix for the treatment of multiple adjacent gingival recessions
Interventions
- PROCEDURE Root coverage procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2021-08-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04462237
The ClinicalTrials.gov registry entry for NCT04462237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Root coverage procedures is the first listed.
NCT04462237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04462237 about?
NCT04462237 is a clinical study titled "Recombinant Human Platelet-derived Growth Factor in Combination With Collagen Matrix". The present randomized clinical trial is aimed at evaluating the efficacy of recombinant human platelet-derived growth factor in combination with collagen matrix for the treatment of multiple adjacent gingival recessions
What is the current status of trial NCT04462237?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-09-09. Estimated completion is 2021-08-18.
What interventions are being tested in trial NCT04462237?
The interventions under investigation include: Root coverage procedures (PROCEDURE).
Who is sponsoring clinical trial NCT04462237?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.